Codexis, Inc.
CDXSNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $118.37M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.96$2.98
- Volume (live)
- -
- Avg. volume (3M)
- 869.15K
Codexis (CDXS) Stock Price & Financial Analysis
Codexis Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.29 - $1.33 |
|---|---|
| 52-Week High | $2.98 |
| 52-Week Low | $0.96 |
| Open | $1.29 |
| Volume (last close) | 501.52K |
| Average Volume (3M) | 869.15K |
| Revenue (TTM) | 77.68M |
|---|---|
| Net Income (TTM) | -30.72M |
| Free Cash Flow (TTM) | -12.18M |
| EPS (TTM) | −$0.34 |
| Profit Margin | -39.55% |
| Operating Margin | -31.22% |
| Return on Equity (ROE) | -93.22% |
| Debt to Equity | 1.24 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 118.37M |
|---|---|
| Shares Outstanding | 91.05M |
| Price to Sales (P/S) | 1.52 |
| Price to Book (P/B) | 3.59 |
| EV/EBITDA | -5.78 |
| 50-Day MA | $1.45 |
|---|---|
| 200-Day MA | $1.83 |
| 1-Year Change | −49.81% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Codexis at a Glance
As of the Oct 22, 2026 close, Codexis (CDXS) has a market capitalization of $118.37M. The stock trades at 1.5× sales. Over the trailing twelve months it lost $30.72M on revenue of $77.68M and burned $12.18M of free cash flow. Revenue grew 35.9% year over year.
As of its latest reported balance sheet, it holds $27.17M in cash and securities against $40.88M of debt, a net debt position of $13.70M.
Codexis does not currently pay a dividend.
The share price is down 49.8% over the past year. At $1.30 (the Oct 22, 2026 close) it sits within its 52-week range of $0.96 to $2.98, below its 200-day moving average of $1.83.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $6.50, 400.0% above the Oct 22, 2026 close.
Frequently Asked Questions About Codexis
What is the current stock price for CDXS?
As of the Oct 22, 2026 close, CDXS stock trades at $1.30. The 52-week range is $0.96–$2.98, with a day range of $1.29–$1.32.
What is the P/E ratio for CDXS?
The P/E ratio (Price-to-Earnings) for CDXS is shown in the Key Statistics section. This valuation metric helps compare Codexis, Inc. to industry peers.
Does CDXS pay dividends?
Codexis does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CDXS?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for CDXS is Buy. The average 12-month price target is $6.50, a 400.0% upside from the Oct 22, 2026 close of $1.30.
What is the market cap of CDXS?
As of the Oct 22, 2026 close, Codexis's market capitalization is $118.4M, classifying it as a micro-cap company. Codexis operates in the Healthcare sector within the Biotechnology industry.